Skip to main content
PMC home page
Cancers logoLink to Cancers
. 2021 Feb 26;13(5):971. doi: 10.3390/cancers13050971

Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748

Manabu Kojima 1,2,†, Kotaro Sugimoto 1,*,†, Mizuko Tanaka 1, Yuta Endo 1, Hitomi Kato 1, Tsuyoshi Honda 3, Shigenori Furukawa 2, Hiroshi Nishiyama 3, Takafumi Watanabe 2, Shu Soeda 2, Keiya Fujimori 2, Hideki Chiba 1,*
PMCID: PMC7956676

The authors wish to make the following correction to this paper [1].

The authors would like to acknowledge Yuko Hashimoto and Shigeyuki Asano for providing cancer tissues. Therefore, the following sentence should be added in the “Acknowledgments” section:

“We are also grateful to Yuko Hashimoto and Shigeyuki Asano for providing cancer tissues.”

The authors would like to apologize for this omission from the original manuscript. The change does not affect the scientific results.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Kojima M., Sugimoto K., Tanaka M., Endo Y., Kato H., Honda T., Furukawa S., Nishiyama H., Watanabe T., Soeda S., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers. 2020;12:2748. doi: 10.3390/cancers12102748. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES